Nicole Notar Nicole Notar

The Exclusion of Women from Clinical Trials: A Historical Perspective

In 1977, the U.S. Food and Drug Administration (FDA) issued guidelines that effectively excluded women of childbearing potential from early-phase clinical trials. The rationale behind this decision was to protect potential pregnancies and unborn children from the potentially harmful effects of experimental drugs. However, this well-intentioned policy had far-reaching consequences for women's health research.

Read More

Ensuring Top-Quality Care for All Facing Endometriosis